by admin | Nov 11, 2024 | in-the-news
Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial
by admin | Jun 6, 2024 | in-the-news
Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial
by admin | Jan 3, 2024 | in-the-news
FDA Grants Fast Track, Breakthrough Therapy Designations to Cretostimogene Grenadenorepvec for NMIBC
by admin | Dec 6, 2023 | in-the-news
by admin | Dec 5, 2023 | in-the-news
by admin | Dec 4, 2023 | in-the-news